Clinical Trials Logo
  1. Home
  2. Heparin
  3. NCT04355273

Effects of Different Concentrations of Pressurized-heparin Flushing Fluid on Coagulation and Platelet Function Monitored by the Sonoclot Analyzer

Heparin Clinical Trial

Official title:
Effects of Different Concentrations of Pressurized-heparin Flushing Fluid on Coagulation and Platelet Function Monitored by the Sonoclot Analyzer

Clinical Trial Summary

Heparin diluent or normal saline is generally used as the arterial tube flushing in clinical practice, but there is no consensus on the choice of flushing fluid. Heparin can affect the blood coagulation function, and even lead to heparin-related thrombocytopenia, increasing the risk of perioperative embolism. Sonoclot is a blood viscoelasticity test, which can provide comprehensive information on the coagulation's cascade and the entire process and be quicker and more effective than routine laboratory coagulation tests. In this research, the coagulation and platelet function analyzer called Sonoclot is used to evaluate the effect of different concentrations of pressurized heparin on the coagulation and platelet function of perioperative patients, which can provide a reference for the clinical choice of appropriate arterial flushing.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04355273
Study type Interventional
Source Yangzhou University
Contact
Status Completed
Phase N/A
Start date January 24, 2018
Completion date December 1, 2019
View Details
See also
  Status Clinical Trial Phase
Completed NCT03470727 - The Effect of Citrate Dialysate on Clot Formation and Anemia in Hemodialysis Patients N/A
Recruiting NCT04496362 - Veno-venous Extracorporeal Membrane Oxygenation (VV-ECMO) Heparin Study Phase 4
Recruiting NCT05875272 - Interchangeability of Arterial Coagulation and Venous Coagulation, in the Context of Cardiac Surgeries Under Cardiopulmonary Bypass, Using the DMDiv Hemochron Signature Elite
Completed NCT03143569 - Ventricular Assist Device Anti-Factor Xa (VAD ANTIX) Monitoring Study: a Prospective Randomized Feasibility Trial N/A
Recruiting NCT04861922 - Unfractioned Heparin for Treatment of Sepsis Caused by Abdominal Infection Phase 3
Completed NCT04767113 - Continuous Heparin Infusion to Prevent Catheter-related Thrombosis N/A
Completed NCT05439265 - EMR Tool Impact on HIT Documentation and Management
Recruiting NCT06109155 - The Effect of ACT and Tranexamic Acid on Bleeding in Cardiac Surgery Phase 4
Withdrawn NCT01454869 - The Effect of Heparin on Inhalation Injury Phase 3
Suspended NCT03125187 - Study With Heparin Sodium in Intravenous Administration Phase 1
Completed NCT05280106 - Citrate Dialysate in Online Hemodialfiltration N/A
Suspended NCT03113084 - Study With Heparin Sodium in Subcutaneous Administration Phase 1
Not yet recruiting NCT03113708 - The Effect of Heparinization Due to LBW Phase 4
Active, not recruiting NCT02785575 - Adjusted Calculation of Heparin and Protamin Dosing and Correlation With Postoperative Bleeding and Transfusions Phase 4